top of page
Blog
Qiagen to acquire Parse Biosciences
QIAGEN has announced its plans to acquire Parse Biosciences, a rapidly growing company known for its instrument-free single-cell technology.
Nov 5, 20251 min read
Dysregulated RNA splicing impairs regeneration in alcohol-associated liver disease
patients with alcohol-associated liver disease have impaired liver regeneration capacity even after cessation of alcohol consumption
Sep 19, 20251 min read
ArgenTag launches its demultiplexing software for their single-cell RNA-seq kit
ArgenTag is democratizing single-cell sequencing using long-read technology. Its single-cell RNA library kit is compatible with long-read sequencing platforms such as Oxford Nanopore and PacBio.
Sep 2, 20251 min read
Illumina CEO envisions stable growth despite uncertainty
Thaysen assures that Illumina will achieve solid growth by 2027, driven by its commitment to multiomics and a strategy tailored to researchers.
Aug 29, 20251 min read
bottom of page